View Full Paper

Owner Consent Verified
Coursework 4.3

Scaling And Replication in Explainable AI for Pharmaceutical Firms: Evidence from North America

13
Pages
APA
Style
~ 13–19 mins
Reading Time
Health Metaverse Impact
Abstract

This coursework investigates “Scaling And Replication in Explainable AI for Pharmaceutical Firms: Evidence from North America” using a propensity score matching. Through a socio-technical lens, the analysis integrates multi-source data to derive an actionable roadmap for researchers and practitioners.

Download PDF Order Similar Paper Save

Scaling And Replication in Explainable AI for Pharmaceutical Firms: Evidence from North America

ABSTRACT
Scaling And Replication in Explainable AI for Pharmaceutical Firms: Evidence from North America is unpacked across themes: risks, KPIs, scalability, and governance. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
33 Pages 4.3
Clinical Trials and Adoption Barriers among Cross-functional Tech Teams — Evidence from Southeast Asia
Data Privacy Sustainability Risk
View Paper
40 Pages 4.9
Corporate Governance Adoption in Regulated Utilities: Governance And Risk — Evidence from Europe
RPA Health Education
View Paper
14 Pages 4.2
Change Management in Mental Health for Export-Oriented Manufacturers: A Comparative Perspective
NLP Cold Chain Food Systems
View Paper